📉 Black women least likely to get post-fracture Rx
📉 Black women least likely to get post-fracture Rx
In a Medicare claims study of 722,022 older women with an incident fracture, just 8.7% started osteoporosis treatment within 2 years — and non-Hispanic Black women were least likely to do so at 7.0%, versus 16.8% for Asian American/Pacific Islander women. The study found Black women had a 35% lower adjusted rate of treatment initiation than non-Hispanic White women (HR 0.65), with the gap even wider among those with more comorbidity.
Why It Matters To Your Practice
NPs and PAs are often the first clinicians to catch the missed moment after a fracture — when secondary prevention should start, not stall.
A fragility fracture is a major osteoporosis red flag, yet treatment initiation remained strikingly low across the cohort.
The biggest treatment gap fell on non-Hispanic Black women, signaling a frontline equity problem that your assessment, follow-up, and prescribing workflows can directly influence.
Clinical Benefits
Post-fracture osteoporosis therapy lowers the risk of subsequent fractures, and intravenous zoledronic acid has also been shown to reduce mortality.
Identifying eligible patients after fracture gives you a high-yield chance to prevent repeat injury, hospitalization, and functional decline.
Your role is not "backup" to physicians here — it is central: NPs and PAs frequently drive medication reconciliation, bone-health counseling, referral coordination, and treatment initiation.
Managing Risks
Build fracture follow-up protocols that prompt bone-health review regardless of race, age, or comorbidity burden.
Pay extra attention to patients with higher comorbidity, since disparities were even greater among non-Hispanic Black women with Charlson Comorbidity Index 1 or higher.
Screen for barriers that derail initiation: cost, transportation, competing illnesses, low awareness that a fracture may signal osteoporosis, and fragmented specialty follow-up.
The Bottom Line
This nationwide study suggests post-fracture osteoporosis treatment is underused overall and especially underused in non-Hispanic Black women.
Frontline clinicians who own the transition from fracture care to prevention — especially NPs and PAs — are in prime position to close that gap.
If you make post-fracture treatment a routine next step instead of an optional add-on, you can help prevent the next fracture and narrow an important disparity.